NEW BRUNSWICK, N.J. – Dr. Jonathan H. Sherman, a specialist in neurosurgical oncology, has been named chief of Neurosurgical Oncology at Rutgers Cancer Institute, officials …
By Pritam Biswas (Reuters) -Cancer drug developer CG Oncology notched up a valuation of $1.75 billion in its market debut on Thursday, after its shares …
NEWARK, N.J. – A New Jersey doctor today admitted using his medical license – and allowing other to use his medical license – to purchase …
BEDMINSTER, N.J., 3 juin 2022 — Jubilant Therapeutics Inc., une société de thérapies de précision au stade clinique qui fait progresser les petites molécules thérapeutiques …
BEDMINSTER, N.J., 3 juin 2022 — Jubilant Therapeutics Inc., une société de thérapies de précision au stade clinique qui fait progresser les petites molécules thérapeutiques …
BEDMINSTER, N.J., 3. Juni 2022 — Jubilant Therapeutics Inc., ein Unternehmen für Präzisionstherapeutika in der klinischen Phase, das niedermolekulare Therapeutika für ungedeckten medizinischen Bedarf in …
These data are part of a New Drug Application that has been granted priority review by the U.S. Food and Drug Administration PRINCETON, N.J., June …
NEWARK, N.J. – A New York doctor today admitted using his medical license – and allowing others to use his medical license – to purchase …